TRDMT1 and cancer: In fact, in a study by Lyko and co-workers, complete inhibition of Dmnt2-mediated 5-cytosine tRNA methylation with azacytidine in cancer cells reduced their proliferative capacity, supporting the notion that reduced cytosine-5 methylation of tRNAs may be an efficient cancer therapeutic strategy [50].